Neurocrine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.
NBIX Key Statistics
Stock Snapshot
As of today, Neurocrine(NBIX) shares are valued at $166.00. The company's market cap stands at 16.94B, with a P/E ratio of 25.91.
During the trading session on 2026-06-28, Neurocrine(NBIX) shares reached a daily high of $169.56 and a low of $163.01. At a current price of $166.00, the stock is +1.8% higher than the low and still -2.1% under the high.
Trading activity shows a volume of 1.95M, compared to an average daily volume of 1.32M.
The stock's 52-week range extends from a low of $122.14 to a high of $169.57.
The stock's 52-week range extends from a low of $122.14 to a high of $169.57.
NBIX News
...
With inflation trends, central bank decisions and bond yields all pulling markets in different directions, many investors are looking for a steadier core for th...
Earlier in June 2026, Neurocrine Biosciences reported new data at ENDO 2026 showing CRENESSITY (crinecerfont) delivered strong hormonal control and glucocortico...
Analyst ratings
88%
of 32 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.